Foghorn Therapeutics Inc (FHTX) — Strategic Asset Allocation Index
Foghorn Therapeutics Inc (FHTX) has a Strategic Asset Allocation Index of 44104.5% as of December 2022. Strategic assets (PP&E of $49.40 Million plus long-term investments of $-) total $49.40 Million, measured against net assets of $112.00K. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Foghorn Therapeutics Inc Strategic Asset Allocation Index (2020–2022)
This chart shows how Foghorn Therapeutics Inc's Strategic Asset Allocation Index has evolved across 3 annual periods from 2020 to 2022. As of December 2022, the index stands at 44104.5%, representing strategic assets of $49.40 Million against net assets of $112.00K USD. Explore FHTX cash generation efficiency to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Foghorn Therapeutics Inc (2020–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Foghorn Therapeutics Inc from 2020 to 2022, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see FHTX company net worth.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 44104.5% | $49.40 Million | $49.40 Million | $- | $112.00K | ▲ +44046.6 pp |
| 2021 | 57.9% | $56.08 Million | $56.08 Million | $- | $96.87 Million | ▲ +15.3 pp |
| 2020 | 42.6% | $62.33 Million | $62.33 Million | $- | $146.19 Million | — |